Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study

被引:2
|
作者
Nussbaum, Eliezer Zachary [1 ,4 ]
Koo, Sophia [2 ]
Kotton, Camille N. [3 ]
机构
[1] Tufts Med Ctr, Dept Geog Med & Infect Dis, Boston, MA USA
[2] Brigham & Womens Hosp, Div Infect Dis, Boston, MA USA
[3] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA USA
[4] Tufts Univ, Tufts Med Ctr, Dept Geog Med & Infect Dis, Sch Med, 800 Washington St,Holmes Bldg Off 509, Boston, MA 02111 USA
关键词
solid organ transplant; bacteremia; oral antibiotics; immunocompromised host; THERAPY; TRIAL;
D O I
10.1093/cid/ciae007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background We assessed the safety and efficacy of oral antibiotic step-down therapy for uncomplicated gram-negative blood stream infections in solid-organ transplant recipients.Methods We identified all solid-organ transplant recipients within the Massachusetts General and Brigham and Women's Hospital systems from 2016 to 2021 with uncomplicated gram-negative bacteremia involving an organism susceptible to an acceptably bioavailable oral antibiotic agent. Using inverse probability of treatment-weighted models based on propensity scores adjusting for potential clinical confounders, we compared outcomes of those transitioned to oral antibiotics with those who continued intravenous (IV) therapy for the duration of treatment. Primary endpoints were mortality, bacteremia recurrence, and reinitiation of IV antibiotics. Secondary endpoints included length of stay, Clostridioides difficile infection, treatment-associated complications, and tunneled central venous catheter placement.Results A total of 120 bacteremia events from 107 patients met inclusion criteria in the oral group and 42 events from 40 patients in the IV group. There were no significant differences in mortality, bacteremia recurrence, or reinitiation of IV antibiotics between groups. Patients transitioned to oral antibiotics had an average length of stay that was 1.97 days shorter (95% confidence interval [CI], -.39 to 3.56 days; P = .005). Odds of developing C. difficile and other treatment-associated complications were 8.4 times higher (95% CI, 1.5-46.6; P = .015) and 6.4 times higher (95% CI, 1.9-20.9; P = .002), respectively, in the IV group. Fifty-five percent of patients in the IV group required tunneled catheter placement. There was no difference in treatment duration between groups.Conclusions Oral step-down therapy was effective and associated with fewer treatment-related adverse events. In solid-organ transplant recipients, treatment of uncomplicated gram-negative bloodstream infections with oral antibiotics was safe, effective, and associated with fewer adverse events and shorter length of hospital stay compared with continued intravenous treatment. Graphical Abstract This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/oral-antibiotics-for-treatment-of-gram-negative-bacteremia-in-solid-organ-transplant-recipients-a-propensity-score-weighted-retrospective-observational-study
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [1] Time to Antibiotics in Solid Organ Transplant Recipients With Gram-Negative Rod Bloodstream Infections
    Thomason, Jenna L.
    Jain, Rupali
    Limaye, Ajit P.
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (12) : 1868 - U195
  • [2] Gram-negative bacteremia in solid organ transplant recipients: Clinical characteristics and outcomes as compared to immunocompetent non-transplant recipients
    Eichenberger, Emily M. M.
    Troy, Jesse
    Ruffin, Felicia
    Dagher, Michael
    Thaden, Joshua T. T.
    Ford, Mandy L. L.
    Fowler Jr, Vance G. G.
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [3] Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study
    Yanik Yalcin, Tugba
    Azap, Ozlem
    Kose, Adem
    Bayindir, Yasar
    Saricaoglu, Elif Mukime
    Cinar, Gule
    Uygun Kizmaz, Yesim
    KurSun, Ebru
    Aliskan, Hikmet Eda
    Tezer Tekce, Yasemin
    Eren Kutsoylu, Oya Ozlem
    EgelI, Tufan
    Ari, Alpay
    Albayrak, Yurdagul
    Cabadak, Hatice
    Deniz, Secil
    Demir Onder, Kubra
    KizilateS, Filiz
    Ozger, Selcuk
    Guzel Tunccan, Ozlem
    Haberal, Mehmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1960 - 1968
  • [4] Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias
    QQ. Wan
    QF. Ye
    H. Yuan
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 431 - 437
  • [5] Incidence Rate and Outcome of Gram-Negative Bloodstream Infection in Solid Organ Transplant Recipients
    Al-Hasan, M. N.
    Razonable, R. R.
    Eckel-Passow, J. E.
    Baddour, L. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (04) : 835 - 843
  • [6] Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli
    Wan, Qiquan
    Luo, Aijing
    Ye, Qifa
    Liu, Shan
    Zhou, Jiandang
    INFECTIOUS DISEASES, 2016, 48 (01) : 32 - 39
  • [7] The Effectiveness and Safety of the Short-Course Therapy in Liver Transplant Recipients With Uncomplicated Gram-Negative Bacteremia: A Retrospective Study
    Miwa, Toshiki
    Okamoto, Koh
    Ishikawa, Shotaro
    Ikeuchi, Kazuhiko
    Yamamoto, Shinya
    Ikeda, Mahoko
    Okugawa, Shu
    Ichida, Akihiko
    Akamatsu, Nobuhisa
    Hasegawa, Kiyoshi
    Tsutsumi, Takeya
    TRANSPLANT INFECTIOUS DISEASE, 2025, 27 (01)
  • [8] Early Switch From Intravenous to Oral Antibiotics for Patients With Uncomplicated Gram-Negative Bacteremia
    Tingsgard, Sandra
    Israelsen, Simone Bastrup
    Jorgensen, Henrik Lovendahl
    Ostergaard, Christian
    Benfield, Thomas
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352314
  • [9] Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients
    Tossey, Justin C.
    El Boghdadly, Zeinab
    Reed, Erica E.
    Dela-Pena, Jennifer
    Coe, Kelci
    Williams, Sherry N.
    Wardlow, Lynn C.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (09) : 5057 - 5064
  • [10] Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients
    Justin C. Tossey
    Zeinab El Boghdadly
    Erica E. Reed
    Jennifer Dela-Pena
    Kelci Coe
    Sherry N. Williams
    Lynn C. Wardlow
    Supportive Care in Cancer, 2021, 29 : 5057 - 5064